| Bryan J Canty, MD | |
|
2800 10th Ave N, Billings, MT 59101 | |
| (406) 238-2500 | |
| Not Available |
| Full Name | Bryan J Canty |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 31 Years |
| Location | 2800 10th Ave N, Billings, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841309515 | NPI | - | NPPES |
| 0055981 | Other | MT | MDCD PIN |
| 000093135 | Other | MT | BCSB PIN |
| 118198000 | Other | WY | MDCD PIN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Metro Health Hospital | Wyoming, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Metropolitan Hospital | 5597651836 | 352 |
| Metropolitan Hospital | 5597651836 | 352 |
News Archive
Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient's HPV status provides an effective indicator of improved patient outcome, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.
Asynt has announced new inserts for its DrySyn heating blocks enabling scientists to now conduct precise temperature controlled, stirred experiments in 0.5-2 ml tapered, 2-5 ml and 10-20 ml microwave vials.
With a $1.5 million grant from the National Science Foundation's Computer Systems Research program, researchers from Clemson University and Dartmouth College launched the Amulet project to develop computational jewelry to support mobile-health applications.
A Canadian judge on Monday acquitted New Jersey-based Armour Pharmaceutical Company and four Canadian doctors - including the former medical director of the Canadian Red Cross and two government officials - of charges related to blood products contaminated with HIV and hepatitis C, the New York Times reports (Austen, New York Times, 10/2).
ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncology drug development company specializing in proprietary antibody drug conjugates, and Five Prime Therapeutics, Inc., a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced an exclusive license agreement for human antibodies directed to an undisclosed target expressed on the surface of various types of cancers.
› Verified 8 days ago
| Entity Name | Livingston Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245222306 PECOS PAC ID: 5991613598 Enrollment ID: O20031122000111 |
News Archive
Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient's HPV status provides an effective indicator of improved patient outcome, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.
Asynt has announced new inserts for its DrySyn heating blocks enabling scientists to now conduct precise temperature controlled, stirred experiments in 0.5-2 ml tapered, 2-5 ml and 10-20 ml microwave vials.
With a $1.5 million grant from the National Science Foundation's Computer Systems Research program, researchers from Clemson University and Dartmouth College launched the Amulet project to develop computational jewelry to support mobile-health applications.
A Canadian judge on Monday acquitted New Jersey-based Armour Pharmaceutical Company and four Canadian doctors - including the former medical director of the Canadian Red Cross and two government officials - of charges related to blood products contaminated with HIV and hepatitis C, the New York Times reports (Austen, New York Times, 10/2).
ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncology drug development company specializing in proprietary antibody drug conjugates, and Five Prime Therapeutics, Inc., a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced an exclusive license agreement for human antibodies directed to an undisclosed target expressed on the surface of various types of cancers.
› Verified 8 days ago
| Entity Name | Big Horn Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891713533 PECOS PAC ID: 5092612796 Enrollment ID: O20031218000807 |
News Archive
Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient's HPV status provides an effective indicator of improved patient outcome, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.
Asynt has announced new inserts for its DrySyn heating blocks enabling scientists to now conduct precise temperature controlled, stirred experiments in 0.5-2 ml tapered, 2-5 ml and 10-20 ml microwave vials.
With a $1.5 million grant from the National Science Foundation's Computer Systems Research program, researchers from Clemson University and Dartmouth College launched the Amulet project to develop computational jewelry to support mobile-health applications.
A Canadian judge on Monday acquitted New Jersey-based Armour Pharmaceutical Company and four Canadian doctors - including the former medical director of the Canadian Red Cross and two government officials - of charges related to blood products contaminated with HIV and hepatitis C, the New York Times reports (Austen, New York Times, 10/2).
ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncology drug development company specializing in proprietary antibody drug conjugates, and Five Prime Therapeutics, Inc., a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced an exclusive license agreement for human antibodies directed to an undisclosed target expressed on the surface of various types of cancers.
› Verified 8 days ago
| Entity Name | Roundup Memorial Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902908262 PECOS PAC ID: 5395646707 Enrollment ID: O20040119000371 |
News Archive
Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient's HPV status provides an effective indicator of improved patient outcome, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.
Asynt has announced new inserts for its DrySyn heating blocks enabling scientists to now conduct precise temperature controlled, stirred experiments in 0.5-2 ml tapered, 2-5 ml and 10-20 ml microwave vials.
With a $1.5 million grant from the National Science Foundation's Computer Systems Research program, researchers from Clemson University and Dartmouth College launched the Amulet project to develop computational jewelry to support mobile-health applications.
A Canadian judge on Monday acquitted New Jersey-based Armour Pharmaceutical Company and four Canadian doctors - including the former medical director of the Canadian Red Cross and two government officials - of charges related to blood products contaminated with HIV and hepatitis C, the New York Times reports (Austen, New York Times, 10/2).
ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncology drug development company specializing in proprietary antibody drug conjugates, and Five Prime Therapeutics, Inc., a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced an exclusive license agreement for human antibodies directed to an undisclosed target expressed on the surface of various types of cancers.
› Verified 8 days ago
| Entity Name | Daniels Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750459632 PECOS PAC ID: 4880685965 Enrollment ID: O20040518001546 |
News Archive
Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient's HPV status provides an effective indicator of improved patient outcome, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.
Asynt has announced new inserts for its DrySyn heating blocks enabling scientists to now conduct precise temperature controlled, stirred experiments in 0.5-2 ml tapered, 2-5 ml and 10-20 ml microwave vials.
With a $1.5 million grant from the National Science Foundation's Computer Systems Research program, researchers from Clemson University and Dartmouth College launched the Amulet project to develop computational jewelry to support mobile-health applications.
A Canadian judge on Monday acquitted New Jersey-based Armour Pharmaceutical Company and four Canadian doctors - including the former medical director of the Canadian Red Cross and two government officials - of charges related to blood products contaminated with HIV and hepatitis C, the New York Times reports (Austen, New York Times, 10/2).
ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncology drug development company specializing in proprietary antibody drug conjugates, and Five Prime Therapeutics, Inc., a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced an exclusive license agreement for human antibodies directed to an undisclosed target expressed on the surface of various types of cancers.
› Verified 8 days ago
| Entity Name | Memorial Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184785099 PECOS PAC ID: 1951375849 Enrollment ID: O20040825001090 |
News Archive
Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient's HPV status provides an effective indicator of improved patient outcome, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.
Asynt has announced new inserts for its DrySyn heating blocks enabling scientists to now conduct precise temperature controlled, stirred experiments in 0.5-2 ml tapered, 2-5 ml and 10-20 ml microwave vials.
With a $1.5 million grant from the National Science Foundation's Computer Systems Research program, researchers from Clemson University and Dartmouth College launched the Amulet project to develop computational jewelry to support mobile-health applications.
A Canadian judge on Monday acquitted New Jersey-based Armour Pharmaceutical Company and four Canadian doctors - including the former medical director of the Canadian Red Cross and two government officials - of charges related to blood products contaminated with HIV and hepatitis C, the New York Times reports (Austen, New York Times, 10/2).
ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncology drug development company specializing in proprietary antibody drug conjugates, and Five Prime Therapeutics, Inc., a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced an exclusive license agreement for human antibodies directed to an undisclosed target expressed on the surface of various types of cancers.
› Verified 8 days ago
| Entity Name | Sheridan Memorial Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891859641 PECOS PAC ID: 9133038706 Enrollment ID: O20040903000553 |
News Archive
Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient's HPV status provides an effective indicator of improved patient outcome, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.
Asynt has announced new inserts for its DrySyn heating blocks enabling scientists to now conduct precise temperature controlled, stirred experiments in 0.5-2 ml tapered, 2-5 ml and 10-20 ml microwave vials.
With a $1.5 million grant from the National Science Foundation's Computer Systems Research program, researchers from Clemson University and Dartmouth College launched the Amulet project to develop computational jewelry to support mobile-health applications.
A Canadian judge on Monday acquitted New Jersey-based Armour Pharmaceutical Company and four Canadian doctors - including the former medical director of the Canadian Red Cross and two government officials - of charges related to blood products contaminated with HIV and hepatitis C, the New York Times reports (Austen, New York Times, 10/2).
ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncology drug development company specializing in proprietary antibody drug conjugates, and Five Prime Therapeutics, Inc., a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced an exclusive license agreement for human antibodies directed to an undisclosed target expressed on the surface of various types of cancers.
› Verified 8 days ago
| Entity Name | Stillwater Hospital Association Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053488387 PECOS PAC ID: 6406889815 Enrollment ID: O20050915001057 |
News Archive
Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient's HPV status provides an effective indicator of improved patient outcome, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.
Asynt has announced new inserts for its DrySyn heating blocks enabling scientists to now conduct precise temperature controlled, stirred experiments in 0.5-2 ml tapered, 2-5 ml and 10-20 ml microwave vials.
With a $1.5 million grant from the National Science Foundation's Computer Systems Research program, researchers from Clemson University and Dartmouth College launched the Amulet project to develop computational jewelry to support mobile-health applications.
A Canadian judge on Monday acquitted New Jersey-based Armour Pharmaceutical Company and four Canadian doctors - including the former medical director of the Canadian Red Cross and two government officials - of charges related to blood products contaminated with HIV and hepatitis C, the New York Times reports (Austen, New York Times, 10/2).
ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncology drug development company specializing in proprietary antibody drug conjugates, and Five Prime Therapeutics, Inc., a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced an exclusive license agreement for human antibodies directed to an undisclosed target expressed on the surface of various types of cancers.
› Verified 8 days ago
| Entity Name | Colstrip Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821063868 PECOS PAC ID: 8224023296 Enrollment ID: O20051027001103 |
News Archive
Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient's HPV status provides an effective indicator of improved patient outcome, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.
Asynt has announced new inserts for its DrySyn heating blocks enabling scientists to now conduct precise temperature controlled, stirred experiments in 0.5-2 ml tapered, 2-5 ml and 10-20 ml microwave vials.
With a $1.5 million grant from the National Science Foundation's Computer Systems Research program, researchers from Clemson University and Dartmouth College launched the Amulet project to develop computational jewelry to support mobile-health applications.
A Canadian judge on Monday acquitted New Jersey-based Armour Pharmaceutical Company and four Canadian doctors - including the former medical director of the Canadian Red Cross and two government officials - of charges related to blood products contaminated with HIV and hepatitis C, the New York Times reports (Austen, New York Times, 10/2).
ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncology drug development company specializing in proprietary antibody drug conjugates, and Five Prime Therapeutics, Inc., a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced an exclusive license agreement for human antibodies directed to an undisclosed target expressed on the surface of various types of cancers.
› Verified 8 days ago
| Entity Name | Mccone County Health Center Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1790803369 PECOS PAC ID: 8921078957 Enrollment ID: O20091008000396 |
News Archive
Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient's HPV status provides an effective indicator of improved patient outcome, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.
Asynt has announced new inserts for its DrySyn heating blocks enabling scientists to now conduct precise temperature controlled, stirred experiments in 0.5-2 ml tapered, 2-5 ml and 10-20 ml microwave vials.
With a $1.5 million grant from the National Science Foundation's Computer Systems Research program, researchers from Clemson University and Dartmouth College launched the Amulet project to develop computational jewelry to support mobile-health applications.
A Canadian judge on Monday acquitted New Jersey-based Armour Pharmaceutical Company and four Canadian doctors - including the former medical director of the Canadian Red Cross and two government officials - of charges related to blood products contaminated with HIV and hepatitis C, the New York Times reports (Austen, New York Times, 10/2).
ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncology drug development company specializing in proprietary antibody drug conjugates, and Five Prime Therapeutics, Inc., a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced an exclusive license agreement for human antibodies directed to an undisclosed target expressed on the surface of various types of cancers.
› Verified 8 days ago
| Entity Name | Powder River County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851791750 PECOS PAC ID: 2860543667 Enrollment ID: O20141105000008 |
News Archive
Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient's HPV status provides an effective indicator of improved patient outcome, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.
Asynt has announced new inserts for its DrySyn heating blocks enabling scientists to now conduct precise temperature controlled, stirred experiments in 0.5-2 ml tapered, 2-5 ml and 10-20 ml microwave vials.
With a $1.5 million grant from the National Science Foundation's Computer Systems Research program, researchers from Clemson University and Dartmouth College launched the Amulet project to develop computational jewelry to support mobile-health applications.
A Canadian judge on Monday acquitted New Jersey-based Armour Pharmaceutical Company and four Canadian doctors - including the former medical director of the Canadian Red Cross and two government officials - of charges related to blood products contaminated with HIV and hepatitis C, the New York Times reports (Austen, New York Times, 10/2).
ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncology drug development company specializing in proprietary antibody drug conjugates, and Five Prime Therapeutics, Inc., a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced an exclusive license agreement for human antibodies directed to an undisclosed target expressed on the surface of various types of cancers.
› Verified 8 days ago
| Entity Name | Kettering Network Radiologists Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346299153 PECOS PAC ID: 7618960303 Enrollment ID: O20180525001315 |
News Archive
Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient's HPV status provides an effective indicator of improved patient outcome, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.
Asynt has announced new inserts for its DrySyn heating blocks enabling scientists to now conduct precise temperature controlled, stirred experiments in 0.5-2 ml tapered, 2-5 ml and 10-20 ml microwave vials.
With a $1.5 million grant from the National Science Foundation's Computer Systems Research program, researchers from Clemson University and Dartmouth College launched the Amulet project to develop computational jewelry to support mobile-health applications.
A Canadian judge on Monday acquitted New Jersey-based Armour Pharmaceutical Company and four Canadian doctors - including the former medical director of the Canadian Red Cross and two government officials - of charges related to blood products contaminated with HIV and hepatitis C, the New York Times reports (Austen, New York Times, 10/2).
ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncology drug development company specializing in proprietary antibody drug conjugates, and Five Prime Therapeutics, Inc., a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced an exclusive license agreement for human antibodies directed to an undisclosed target expressed on the surface of various types of cancers.
› Verified 8 days ago
| Entity Name | Metropolitan Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811937519 PECOS PAC ID: 5597651836 Enrollment ID: O20201014002817 |
News Archive
Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient's HPV status provides an effective indicator of improved patient outcome, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.
Asynt has announced new inserts for its DrySyn heating blocks enabling scientists to now conduct precise temperature controlled, stirred experiments in 0.5-2 ml tapered, 2-5 ml and 10-20 ml microwave vials.
With a $1.5 million grant from the National Science Foundation's Computer Systems Research program, researchers from Clemson University and Dartmouth College launched the Amulet project to develop computational jewelry to support mobile-health applications.
A Canadian judge on Monday acquitted New Jersey-based Armour Pharmaceutical Company and four Canadian doctors - including the former medical director of the Canadian Red Cross and two government officials - of charges related to blood products contaminated with HIV and hepatitis C, the New York Times reports (Austen, New York Times, 10/2).
ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncology drug development company specializing in proprietary antibody drug conjugates, and Five Prime Therapeutics, Inc., a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced an exclusive license agreement for human antibodies directed to an undisclosed target expressed on the surface of various types of cancers.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bryan J Canty, MD Po Box 35100, Billings, MT 59107-5100 Ph: (406) 238-2500 | Bryan J Canty, MD 2800 10th Ave N, Billings, MT 59101 Ph: (406) 238-2500 |
News Archive
Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient's HPV status provides an effective indicator of improved patient outcome, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.
Asynt has announced new inserts for its DrySyn heating blocks enabling scientists to now conduct precise temperature controlled, stirred experiments in 0.5-2 ml tapered, 2-5 ml and 10-20 ml microwave vials.
With a $1.5 million grant from the National Science Foundation's Computer Systems Research program, researchers from Clemson University and Dartmouth College launched the Amulet project to develop computational jewelry to support mobile-health applications.
A Canadian judge on Monday acquitted New Jersey-based Armour Pharmaceutical Company and four Canadian doctors - including the former medical director of the Canadian Red Cross and two government officials - of charges related to blood products contaminated with HIV and hepatitis C, the New York Times reports (Austen, New York Times, 10/2).
ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncology drug development company specializing in proprietary antibody drug conjugates, and Five Prime Therapeutics, Inc., a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced an exclusive license agreement for human antibodies directed to an undisclosed target expressed on the surface of various types of cancers.
› Verified 8 days ago
Dr. Heather I Gale, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2800 10th Ave N, Billings, MT 59101 Phone: 406-238-5046 Fax: 406-247-6053 | |
Rebecca Susan Tarlton, MD Radiology Medicare: Medicare Enrolled Practice Location: 1315 Golden Valley Cir, Billings, MT 59102 Phone: 406-238-6290 Fax: 406-238-6280 | |
Dr. Brian Matthew Christenson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 406-237-5491 Fax: 406-237-5499 | |
Dr. Joseph Paul Dillard, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2900 12th Ave N, Suite 210w, Billings, MT 59101 Phone: 406-237-5862 Fax: 406-238-6068 | |
Dr. Robert Rex Dietz, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2900 12th Ave N, Suite 210w, Billings, MT 59101 Phone: 406-237-5862 Fax: 406-238-6068 | |
Tara S Bowman Seitz, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2800 10th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
John M. Schallenkamp, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 |